We are live on ! Find out more
RG

Renaissance Group Portfolio holdings

AUM $2.39B
1-Year Est. Return 27.81%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+27.81%
3 Year Est. Return
+92.11%
5 Year Est. Return
+135.4%
10 Year Est. Return
+451.85%
AUM
$2.43B
AUM Growth
-$134M
Cap. Flow
-$248M
Cap. Flow %
-10.2%
Top 10 Hldgs %
17.32%
Holding
302
New
25
Increased
58
Reduced
131
Closed
62

Top Buys

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$32.4M
2
TW icon
Tradeweb Markets
TW
+$32M
3
KKR icon
KKR & Co
KKR
+$31.7M
4
APP icon
Applovin
APP
+$28.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28M

Sector Composition

Rank Sector Weight
1 Technology 33.13%
2 Healthcare 13.65%
3 Consumer Discretionary 11.83%
4 Financials 11.41%
5 Industrials 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIMS icon
101
Hims & Hers Health
HIMS
$6.94B
$4.13M 0.17%
+223,964
New +$4.01M
EXLS icon
102
EXL Service
EXLS
$5.21B
$4.09M 0.17%
107,141
+8,029
+8% +$280K
HURN icon
103
Huron Consulting
HURN
$2.39B
$4.03M 0.17%
37,103
+2,792
+8% +$296K
NMIH icon
104
NMI Holdings
NMIH
$3.31B
$4.02M 0.17%
97,563
+7,194
+8% +$277K
BDC icon
105
Belden
BDC
$5.08B
$4.01M 0.17%
34,269
+2,639
+8% +$265K
CRDO icon
106
Credo Technology Group
CRDO
$43.7B
$4M 0.16%
+129,820
New +$3.87M
BLD
107
DELISTED
TopBuild
BLD
$3.86M 0.16%
9,485
+626
+7% +$253K
VRRM icon
108
Verra Mobility
VRRM
$772M
$3.79M 0.16%
136,152
+10,103
+8% +$284K
MMSI icon
109
Merit Medical Systems
MMSI
$5.25B
$3.74M 0.15%
37,815
+2,854
+8% +$261K
FCN icon
110
FTI Consulting
FCN
$4.18B
$3.73M 0.15%
16,405
+1,217
+8% +$270K
ENSG icon
111
The Ensign Group
ENSG
$10.6B
$3.69M 0.15%
25,653
+1,905
+8% +$271K
LNTH icon
112
Lantheus
LNTH
$6.59B
$3.59M 0.15%
32,750
+2,277
+7% +$237K
SPSC icon
113
SPS Commerce
SPSC
$2.57B
$3.57M 0.15%
18,385
+1,219
+7% +$239K
ADUS icon
114
Addus HomeCare
ADUS
$2.22B
$3.54M 0.15%
26,623
+1,994
+8% +$252K
TSEM icon
115
Tower Semiconductor
TSEM
$25.8B
$3.52M 0.14%
79,513
-6,843
-8% -$280K
MEDP icon
116
Medpace
MEDP
$16.2B
$3.46M 0.14%
10,355
+56
+0.5% +$21.3K
HQY icon
117
HealthEquity
HQY
$8.73B
$3.43M 0.14%
41,902
+2,882
+7% +$222K
AMPH icon
118
Amphastar Pharmaceuticals
AMPH
$868M
$3.39M 0.14%
69,876
+4,858
+7% +$213K
VITL icon
119
Vital Farms
VITL
$501M
$3.37M 0.14%
+96,218
New +$3.4M
ANF icon
120
Abercrombie & Fitch
ANF
$4.94B
$3.37M 0.14%
+24,093
New +$3.67M
JAMF
121
DELISTED
Jamf
JAMF
$3.26M 0.13%
187,875
+12,950
+7% +$230K
OSW icon
122
OneSpaWorld
OSW
$2.68B
$3.22M 0.13%
195,143
-15,844
-8% -$251K
ELF icon
123
e.l.f. Beauty
ELF
$5.5B
$3.18M 0.13%
29,172
+11,092
+61% +$1.74M
ESNT icon
124
Essent Group
ESNT
$6.02B
$3.04M 0.13%
47,337
-4,149
-8% -$254K
CLS icon
125
Celestica
CLS
$36.3B
$2.95M 0.12%
57,751
-4,725
-8% -$244K

Similar funds

Renaissance Group's Q3 2024 Portfolio in Review

As of Q3 2024, Renaissance Group held 302 positions worth $2.43B, down 5.2% from $2.56B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Renaissance Group withdrew a net $248M in Q3 2024, closing 62 positions and reducing 131 holdings. Its most notable exit was Target, an estimated $30M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Renaissance Group opened a new position in Arista Networks worth $35.7M.

  • Renaissance Group's largest Q3 2024 buy was Arista Networks: 372,260 shares worth $35.7M.
  • Renaissance Group added most to Millicom in Q3 2024, an estimated $6.17M increase.
  • Renaissance Group's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $33.7M.
  • Renaissance Group fully exited Target in Q3 2024, selling an estimated $30M.
  • Renaissance Group's ten largest holdings make up 17% of its $2.43B portfolio in Q3 2024.
  • Renaissance Group opened 25 new positions and closed 62 in Q3 2024.
  • Renaissance Group's portfolio value fell 5.2% quarter-over-quarter to $2.43B.

Based on Renaissance Group's 13F filing for Q3 2024, filed 12 Nov 2024.